AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Vir Biotechnology, Inc. Director's Dealing 2019

Oct 11, 2019

32538_dirs_2019-10-10_4477ea77-910c-4c33-94ac-0505ec2733a1.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2019-10-10

Reporting Person: Horn Howard (CFO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	277777	Direct